ICN PHARMACEUTICALS, INC.
Patent Owner
Stats
- 8 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Sep 02, 2003 most recent publication
Details
- 8 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 554 Total Citation Count
- Mar 08, 1979 Earliest Filing
- 15 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6211201 Multivalent salts of pyridostigmine and related compoundsJun 29, 99Apr 03, 01[A61K, C07D, C07C]
6150337 Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytesSep 18, 98Nov 21, 00[A61K, C07H]
6110453 Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using sameJan 26, 98Aug 29, 00[A01N, C08K]
6063772 Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytesJun 15, 98May 16, 00[A61K, C07H]
5767097 Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytesJan 23, 96Jun 16, 98[A61K, C07H]
5763419 Treatment of malignant tumors with 8-chloroadenosine 3',5'-cyclic monophasphateMay 10, 95Jun 09, 98[A61K, C07H]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
6017898 Inhibition of tumor growth by antisense oligonucleotides for IL-8 and IL-8 receptorExpiredApr 06, 98Jan 25, 00[A61K, C07H]
5798250 Facilitating hepatitus virus infection in cell culture using a membrane stressorExpiredApr 15, 96Aug 25, 98[C12N]
5405837 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirinExpiredMay 18, 93Apr 11, 95[A61K]
4849426 Method for treating actinic keratosis with cytotoxic agentsExpiredDec 02, 87Jul 18, 89[A61K]
4820711 Method for treating actinic keratosis with cytotoxic agentsExpiredMay 15, 87Apr 11, 89[A61K]
4594414 2-.beta.-D-ribofuranosylselenazole-4-carboxamide compounds and methods for their productionExpiredJun 22, 84Jun 10, 86[C07H]
4594416 2-.beta.-D-ribofuranosylselenazole-4-carboxamide compounds and methods for their productionExpiredJul 23, 84Jun 10, 86[C07H]
4328336 9-(.beta.-D-Ribofurandsyl)purine-6-carboxamide and related compoundsExpiredAug 26, 80May 04, 82[C07H]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.